Central and Peripheral Neurological Manifestations during Human Immunodeficiency Virus Infection at the Fann National Hospital in Dakar (Senegal)

Diagne Rokhaya

Ibrahima Pierre Ndiaye Neuroscience Clinic, Fann National University Hospital Center (FNUHC), Dakar, Senegal.

Thioub Daouda *

Infectious and Tropical Diseases Department, Fann National University Hospital Center (FNUHC), Dakar, Senegal.

Mbaye Khalifa Ababacar

Ibrahima Pierre Ndiaye Neuroscience Clinic, Fann National University Hospital Center (FNUHC), Dakar, Senegal.

Ka Daye

Infectious and Tropical Diseases Department, Fann National University Hospital Center (FNUHC), Dakar, Senegal.

Ndiaye Moustapha

Ibrahima Pierre Ndiaye Neuroscience Clinic, Fann National University Hospital Center (FNUHC), Dakar, Senegal.

Diop Amadou Gallo

Ibrahima Pierre Ndiaye Neuroscience Clinic, Fann National University Hospital Center (FNUHC), Dakar, Senegal.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Neurological manifestations associated with HIV are frequent, with variable clinical signs. The aim of our study was to characterize the epidemiological, clinical, paraclinical, therapeutic, evolutionary and prognostic aspects of neurological disorders in HIV. 

Methods: This was a descriptive, retrospective and prospective study, from 01 October 2020 to 31 October 2022, conducted in the neurology and infectious and tropical diseases departments of Fann National University Hospital Center (FNUHC) in Dakar (Senegal).

Results: We enrolled 93 patients, 56 of whom were women, i.e. a sex ratio of 1.51. The mean age of the patients was 41 years [18 - 73 years]. The onset of clinical signs was predominantly acute (75%). Headache and confusion were the most common neurological signs, 65% and 57% respectively. Meningoencephalitis was the most common central manifestation (91%), followed by mononeuropathy (19%). The average length of hospitalization was 17.92 days [1 - 78 days] and 20 patients (22%) were put on antiretroviral treatment with an average delay of 32.8 days. Corticosteroid therapy was initiated in 58 patients (62%). Forty-seven patients (51%) died during hospitalization and 46 patients (49%) were followed up. Twenty-nine patients (31%) had a favorable outcome with complete disappearance of signs, and the remaining 17 patients (18%) had neurological sequelae.

Conclusion: During the course of HIV/AIDS infection, morbidity, mortality and neurological damage remain high. Systematic screening for these neurological signs during follow-up of patients living with HIV is necessary in order to improve diagnostic and therapeutic management.

Keywords: Neurology, HIV/AIDS, Senegal


How to Cite

Rokhaya , D., Daouda , T., Ababacar, M. K., Daye, K., Moustapha, N., & Gallo , D. A. (2024). Central and Peripheral Neurological Manifestations during Human Immunodeficiency Virus Infection at the Fann National Hospital in Dakar (Senegal). Asian Journal of Research and Reports in Neurology, 7(1), 1–7. Retrieved from https://journalajorrin.com/index.php/AJORRIN/article/view/97

Downloads

Download data is not yet available.

References

Jia XC, Xia ZH, Shi N et al. The factors associated with natural disease progression from HIV to AIDS in the absence of ART, A propensity score matching analysis. Epidemiol Infect n.d.; 148:e57. Available:https://doi.org/10.1017/S0950268820000540.

CNLS National Council for the Fight against AIDS | Senegal n.d. Available:https://www.cnls-senegal.org (Accessed August 31, 2023).

Uwishema O, Ayoub G, Badri R, et al. Neurological disorders in HIV: Hope despite challenges. Immunity, Inflammation and Disease. 2022;10:e591. Available:https://doi.org/10.1002/iid3.591

Singh R, Kaur M, Arora D. Neurological complications in late-stage hospitalized patients with HIV disease. Ann Indian Acad Neurol. 2011;14:172–7. Available:https://doi.org/10.4103/0972-2327.85878

Soumaré M, Seydi M, Ndour CT et al. Epidemiological, clinical and etiological profile of cerebromeningeal disorders observed at the infectious diseases clinic of Fann University Hospital in Dakar. Medicine and Infectious Diseases. 2005; 35:383–9. Available:https://doi.org/10.1016/j.medmal.2005.03.009

El Fane M, Sodqi M, Chakib A, et al. Central neurological manifestations during human immunodeficiency virus (HIV) infection; 2016.

Dai L, Mahajan SD, Guo C, et al. Spectrum of central nervous system disorders in hospitalized HIV/AIDS patients (2009-2011) at a major HIV/AIDS referral center in Beijing, China. J Neurol Sci. 2014; 342:88–92.

Available:https://doi.org/10.1016/j.jns.2014.04.031

Kabongo JK, Kaputu-Kalala-Malu C, Luboya O, et al. Neuropathies linked to HIV/AIDS: A clinical study in patients infected with HIV at the HIV/AIDS Center of Excellence of the University of Lubumbashi. Pan Afr Med J. 2015;20:392 Available:https://doi.org/10.11604/pamj.2015.20.392.5799

Kouassi B. Retroviral infections in the tropics; 1988.

Adoukonou T, Dassi-Gbenou J, Glele R et al. Epidemiology of neurological conditions in a population of people living with HIV in Parakou in 2014. Revue Neuroologique. 2015;171:A136 Available:https://doi.org/10.1016/j.neurol.2015.01.295

UNAIDS. Senegal | UNAIDS; 2021. Available:https://www.unaids.org/fr/keywords/senegal-0 (Accessed August 31, 2023).

Yilmaz G. Diagnosis of HIV infection and laboratory monitoring of its therapy. J Clin Virol. 2001;21:187–96.

Available:https://doi.org/10.1016/s1386-6532(01)00165-2

Berhe T, Melkamu Y, Amare A. The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: A retrospective study. AIDS Research and Therapy. 2012; 9:11.

Available:https://doi.org/10.1186/1742-6405-9-11

El Fane M, Sodqi M, Lamdini H, et al. Central Neurological Diagnosis in Patients Infected with HIV in the Infectious Diseases Unit of University Hospital of Casablanca, Morocco. Bull Soc Pathol Exot. 2018;111:24–30.

Available:https://doi.org/10.3166/bspe-2018-0004

De Broucker T. Neurological complications of human immunodeficiency virus (HIV) infection. Neurological Practice - FMC 2013;4:213–28. Available:https://doi.org/10.1016/j.praneu.2013.10.002

Mapoure YN, Nkongni IN, Luma HN, et al. Incidence of stroke in HIV- positive patients on long-term antiretroviral therapy. Pan Afr Med J. 2016; 24:45 Available:https://doi.org/10.11604/pamj.2016.24.45.8013

McArthur JC. Neurological manifestations of AIDS. Medicine (Baltimore). 1987;66: 407–37. Available:https://doi.org/10.1097/00005792-198711000-00001.

Moulignier A, Lamirel C, Picard H, et al. Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy. Neurology. 2017; 89:796–804 Available:https://doi.org/10.1212/WNL.0000000000004265.